A detailed history of Ulland Investment Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ulland Investment Advisors, LLC holds 1,506 shares of JNJ stock, worth $218,445. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,506
Previous 1,356 11.06%
Holding current value
$218,445
Previous $198,000 23.23%
% of portfolio
0.18%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$145.48 - $167.38 $21,822 - $25,107
150 Added 11.06%
1,506 $244,000
Q2 2024

Jul 16, 2024

SELL
$144.38 - $157.78 $28,587 - $31,240
-198 Reduced 12.74%
1,356 $198,000
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $38,028 - $39,871
-245 Reduced 13.62%
1,554 $246,000
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $11,069 - $12,571
70 Added 4.05%
1,799 $319,000
Q4 2021

Feb 16, 2022

BUY
$155.93 - $173.01 $269,602 - $299,134
1,729 New
1,729 $296,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ulland Investment Advisors, LLC Portfolio

Follow Ulland Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ulland Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ulland Investment Advisors, LLC with notifications on news.